GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » FFO

Oxford BioDynamics (LSE:OBD) FFO


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics FFO?

FFO (Funds from operations) only applies to REITs.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.